Home > News > SiGen Licenses its NanoBond Process to EV Group
October 31st, 2003
SiGen Licenses its NanoBond Process to EV Group
Silicon Genesis Corporation (SiGen) announced today that it has entered into a license agreement with EV Group of Scharding, Austria (EVG). Under this agreement, SiGen will transfer equipment, process, Intellectual Property (IP) rights and related know-how to EVG to enable the equipment manufacturer to integrate and offer the SiGen NanoBond(TM) technologies in EVG's line of wafer bonding tools.
Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014
A new cheap and efficient method to improve SERS, an ultra-sensitive chemical detection technique October 28th, 2014
New Compact SIMS at 61st AVS | Visit us on Booth 311 October 28th, 2014
New nanodevice to improve cancer treatment monitoring October 27th, 2014